Correlation between Arterial Feeding Embolization and Pleural Effusion Dynamics in Breast Cancer Patients

Authors

  • Edward Iskandar Universitas Sam Ratulangi
  • Adrian Tangkilisan Universitas Sam Ratulangi
  • Wega Sukanto Universitas Sam Ratulangi

DOI:

https://doi.org/10.35790/ecl.v14i1.63867

Keywords:

breast cancer; malignant pleural effusion; transarterial chemoembolization

Abstract

Abstract: Breast cancer is the most common malignancy in women and a leading cause of malignant pleural effusion (MPE). Arterial feeding embolization, as performed in transarterial chemo-embolization (TACE), has the potential to reduce effusion production by obstructing tumor blood supply. This study aimed to evaluate the correlation between arterial embolization and pleural effusion dynamics in patients with breast cancer. This was a prospective cohort study conducted at Prof. Dr. R. D. Kandou Hospital, Manado, from 2022 to 2024. Patients diagnosed with breast cancer were randomly assigned to the TACE or control group. Superselective embolization was performed using a microcatheter and a selected embolic agent to occlude the blood supply to the target lesion. Data were analyzed using SPSS v26 with Shapiro-Wilk normality test, t-test or Mann-Whitney U test, and linear regression. Study phases included subject selection, randomization, and data analysis. The results showed that a total of 21 female patients with breast cancer (mean age 52.19±9.17 years) were enrolled. Eleven patients (52.4%) underwent TACE, while ten (47.6%) did not. Pleural effusion was observed in four patients (19%), more frequently in the non-TACE group (30%) compared to the TACE group (9.1%), though the difference was not statistically significant (p=0.439). Multivariate analysis also revealed no significant association between arterial embolization and pleural effusion (p=0.244; R²=0.071), indicating a low predictive value. Arterial feeding embolization via TACE demonstrated clinical potential in reducing pleural effusion among breast cancer patients, although the results were not statistically significant. The limited efficacy may be attributed to the complex tumor vascularization and heterogeneous biological responses. A multimodal therapeutic approach remains necessary for optimal MPE management. In conclusion, although arterial embolization may clinically reduce tumor perfusion and subsequent effusion formation, this study found no significant correlation between the procedure and pleural effusion reduction. Therefore, arterial embolization alone may not be sufficient as a standalone treatment strategy for managing MPE in breast cancer patients.

Keywords: breast cancer; malignant pleural effusion; transarterial chemoembolization

Author Biographies

Edward Iskandar, Universitas Sam Ratulangi

Department of Surgery, Faculty of Medicine, Universitas Sam Ratulangi, Manado, Indonesia

Adrian Tangkilisan, Universitas Sam Ratulangi

Division of Thorax and Vascular Surgery, Department of Surgery, Universitas Sam Ratulangi – Prof. Dr. R. D. Kandou, Manado, Indonesia

Wega Sukanto, Universitas Sam Ratulangi

Division of Thorax and Vascular Surgery, Department of Surgery, Universitas Sam Ratulangi – Prof. Dr. R. D. Kandou, Manado, Indonesia

References

1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global cancer observatory: cancer today. International Agency for Research on Cancer. 2018;3(20):2019. Available from: https://gco.iarc.fr/today

2. Sharma R. Global, regional, national burden of breast cancer in 185 countries: Evidence from GLOBOCAN 2018. Breast Cancer Res Treat. 2021;187(2):557-67. Doi: 10.1007/s10549-020-06083-6.

3. Park C, Lee J. Massive hemothorax due to intercostal arterial bleeding after percutaneous catheter removal in a multiple-trauma patient: a case report. World J Clin Cases. 2021;9(32):9942. Doi: 10.12998/wjcc.v9.i32.9942

4. Miyayama S. Treatment strategy of transarterial chemoembolization for hepatocellular carcinoma. Appl Sci. 2020;10(20):7337. Doi:10.3390/app10207337

5. Yap E, Anderson G, Donald J, Wong CA, Lee YCG, Sivakumaran P. Pleural effusion in patients with pulmonary embolism. Respirology. 2008;13(6):832-6. Doi: 10.1111/j.1440-1843.2008.01345.x

6. Zhang J, Zhou H, Aili A, Wang M, Yongchun S, Yi Q. Prevalence and clinical significance of pleural effusion in patients with acute pulmonary embolism: a retrospective study. J Thorac Dis. 2021;13(2):541-51. Doi:10.21037/jtd-20-2552

7. Porcel JM, Esquerda A, Vives M, Bielsa S. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol. 2014;50(5):161-5. Doi: 10.1016/j.arbres.2013.11.007

8. Wang G, Zhang J, Liu H, Zheng Q, Sun P. Embolization alone is as effective as TACE for unresectable HCC: systematic review and meta-analysis of randomized controlled trails. BMC Gastroenterol. 2024;24(1):195. Doi: 10.1186/s12876-024-03282-z

9. Mason MC, Massarweh NN, Salami A, Sultenfuss MA, Anaya DA. Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma. HPB (Oxford). 2015;17(12):487. Doi:10.1111/hpb.12487

10. Bedawi EO, Hassan M, Rahman NM. Recent developments in the management of pleural infection: a comprehensive review. Clin Respir J. 2018;12(8):2309. Doi: 10.1111/crj.12941

11. Psallidas I, Kalomenidis I, Porcel JM, Robinson BW, Stathopoulos GT. Malignant pleural effusion: from bench to bedside. Eur Respir Rev. 2016;25(140):189-98. Doi: 10.1183/16000617.0019-2016

12. Chambers DM, Abaid B, Gauhar U. Indwelling pleural catheters for nonmalignant effusions: evidence-based answers to clinical concerns. Am J Med Sci. 2017;354(3):230-5. Doi: 10.1016/j.amjms.2017.03.003

Downloads

Published

2025-12-11

How to Cite

Iskandar, E., Tangkilisan, A., & Sukanto, W. (2025). Correlation between Arterial Feeding Embolization and Pleural Effusion Dynamics in Breast Cancer Patients . E-CliniC, 14(1), 41–45. https://doi.org/10.35790/ecl.v14i1.63867

Issue

Section

Articles